Remote Access to Care, Everywhere, for Parkinson Disease
Completed · Not applicable
Conditions studied: Parkinson Disease
In brief
The primary objective of this study is to evaluate the feasibility, efficacy and the value of providing care to individuals with Parkinson disease directly into their homes. The specific aims are: 1. To demonstrate the feasibility of conducting remote evaluations of patients with Parkinson disease nationally; 2. To measure the impact of remote care on each patient's ability to improve his or her quality of life (QoL) and better manage his or her Parkinson disease; and 3. To assess the long-term acceptability to patients in receiving ongoing care remotely via telemedicine.
Key facts
- Study ID
- NCT02144220
- Run by
- University of Rochester
- People needed
- 277
- Starts
- 2014-03-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2017-02-23
Who can join
Age: 30 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age greater than 30
- Self reported diagnosis of idiopathic Parkinson disease
- Ability to converse in English
- Ability and willingness to provide informed consent and complete study requirements
- Access to a non-public computer or similar devices with broadband internet.
- Located in New York, Maryland, Delaware, California, or Florida at time of virtual visit (or veterans with Parkinson disease anywhere in the U.S.)
You may not qualify if…
- Any condition (e.g.prominent psychosis) that in the investigator's or coordinator's judgment would preclude participation.
- Concurrent enrollment in another telemedicine study.
Where it is running
- University of California San Francisco/San Francisco VA Medical Center — San Francisco, California, United States
- University of Florida — Gainesville, Florida, United States
- University of Rochester Medical Center — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.